HolderBook

ACT CAPITAL MANAGEMENT, LLC

Reported holdings as of Q2 2026, from 9 quarterly filings.

This filer last reported in Q2 2026; the most recent quarter on file across all filers is Q3 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.

CIK
1442273
Reported value
$153.1M
Positions
62
Top 10 weight
66.0%
Filed
2026-07-29
Days after quarter end
29

Holdings

Download these holdings as CSV

SecurityTickerValue SharesWeightWeight change Held Change
KRYSTAL BIOTECH INCKRYS$16.7M45,00010.93%-1.35pp9q-25.6%-$5.8M
TG THERAPEUTICS INCTGTX$13.8M251,0259.01%+2.51pp3q+0.8%+$109.9K
ABIVAX SAABVX$12.9M97,0008.44%+2.24pp3q+36.8%+$3.5M
CHEVRON CORPORATIONCVX$12.4M75,0008.12%-4.07pp8qHELD
EXXON MOBIL CORPXOMXXXX$10.7M78,5007.01%-2.32pp5q+12.1%+$1.2M
ARROWHEAD PHARMACEUTICALS INARWR$9.0M110,1005.86%+1.80pp9q+33.5%+$2.2M
VIKING THERAPEUTICS INCVKTX$8.2M209,3005.33%-0.02pp3qHELD
CELCUITY INCCELC$6.5M62,1504.25%-3.98pp3q-32.2%-$3.1M
NEKTAR THERAPEUTICSNKTR$6.2M89,3004.07%+0.06pp3q+26.0%+$1.3M
TESLA INCTSLA$4.5M10,8002.97%-newNEW
CYTOKINETICS INCCYTK$4.0M47,5002.64%-0.70pp3q-26.4%-$1.4M
AST SPACEMOBILE INCASTS$3.9M43,5002.53%-newNEW
PALVELLA THERAPEUTICS INC NEPVLA$3.4M22,5002.25%-newNEW
AMAZON COM INCAMZN$3.1M12,9002.01%-3.39pp3q-60.9%-$4.8M
NUVATION BIO INCNUVB$3.0M520,0001.93%+0.95pp3q+79.3%+$1.3M
XENON PHARMACEUTICALS INCXENE$2.9M48,0001.89%+0.36pp2q+43.3%+$875.2K
ENERGY TRANSFER L PET$2.5M133,1001.66%-0.36pp5qHELD
BLOOM ENERGY CORPBE$2.3M7,5001.48%+1.00pp3q+66.7%+$908.1K
FREEPORT-MCMORAN INCFCX$2.0M32,5001.34%-0.44pp2q-15.6%-$377.3K
NEBIUS GROUP N.V.NBIS$1.9M6,8001.23%-newNEW
ALUMIS INCALMS$1.5M51,6000.95%-2.07pp2q-70.4%-$3.5M
AMBARELLA INCAMBA$1.4M16,0000.90%-newNEW
CEREBRAS SYSTEMS INCCBRS$1.2M5,6000.81%-newNEW
DEFINIUM THERAPEUTICS INCDFTX$1.2M25,0000.77%-newNEW
NOKIA CORPNOK$1.1M82,0000.71%-newNEW
KURA ONCOLOGY INCKURA$975.2K88,9000.64%+0.16pp3q+20.3%+$164.6K
PRAXIS PRECISION MEDICINES IPRAX$903.9K2,7000.59%-0.09pp3qHELD
APPLIED OPTOELECTRONICS INCAAOI$889.0K6,0000.58%-1.14pp2q-76.8%-$2.9M
CAMECO CORPCCJ$855.6K8,4000.56%-newNEW
MONTE ROSA THERAPEUTICS INCGLUE$847.0K35,0000.55%+0.26pp2q+55.6%+$302.5K
REGENXBIO INCRGNX$808.6K67,5000.53%+0.16pp3q+20.5%+$137.8K
MINERALYS THERAPEUTICS INCMLYS$758.1K28,1000.50%-newNEW
GRAYSCALE BITCOIN TRUST ETFGBTC$701.0K15,4000.46%-0.18pp3qHELD
VIR BIOTECHNOLOGY INCVIR$655.2K64,3000.43%-0.02pp2qHELD
PALISADE BIO INCPALI$642.7K307,5000.42%+0.07pp3q+19.4%+$104.5K
PALANTIR TECHNOLOGIES INCPLTR$641.7K5,5000.42%-newNEW
ON SEMICONDUCTOR CORPON$567.2K6,0000.37%-newNEW
WARRIOR MET COAL INCHCC$487.0K6,0000.32%-0.12pp3qHELD
CRESCENT ENERGY COMPANYCRGY$441.9K45,0000.29%-0.19pp3qHELD
MBX BIOSCIENCES INCMBX$441.6K8,0000.29%+0.08pp2q-11.1%-$55.2K
KEEL INFRASTRUCTURE CORPKEEL$427.6K74,5000.28%-newNEW
COMPASS PATHWAYS PLCCMPS$424.5K30,0000.28%+0.21pp2q+93.5%+$205.2K
CORVUS PHARMACEUTICALS INCCRVS$403.4K27,0000.26%-newNEW
ALPHA COGNITION INCACOG$371.8K51,5000.24%+0.02pp3qHELD
KYVERNA THERAPEUTICS INCKYTX$356.4K40,0000.23%+0.03pp3q+33.3%+$89.1K
AXT INCAXTI$353.2K4,9000.23%-newNEW
INFLEQTION INCINFQ$333.0K25,0000.22%-newNEW
SCHOLAR ROCK HLDG CORPSRRK$330.0K6,0000.22%-0.20pp3q-44.4%-$264.0K
UIPATH INCPATH$326.1K30,0000.21%-0.22pp3q-40.0%-$217.4K
ADLAI NORTYE LTDANL$310.5K27,0000.20%-newNEW
ONDAS INCONDS$309.0K37,5000.20%-0.06pp2qHELD
ARKO PETE CORPAPC$282.8K15,0000.18%-0.03pp2qHELD
RYERSON HLDG CORPRYZ$275.6K11,2000.18%-0.01pp2q+3.7%+$9.8K
GENEDX HOLDINGS CORPWGS$274.6K4,0000.18%-0.22pp3q-50.0%-$274.6K
CAPSTONE GREEN ENERGY CORP COMCEPL$253.0K27,5000.17%-newNEW
MICRON TECHNOLOGY INCMU$230.9K2000.15%-0.25pp2q-86.7%-$1.5M
TERRA INNOVATUM GLOBAL NVNKLR$221.4K45,0000.14%-0.02pp3qHELD
VIVOPOWER PLCVIVO$219.7K42,5000.14%-newNEW
SPACE EXPLORATION TECHN CORPSPCX$136.7K8000.09%-newNEW
LIGHTSPEED COMMERCE INCLSPD$131.1K12,5000.09%flat3qHELD
STRATASYS LTDSSYS$85.6K10,0000.06%-0.01pp8qHELD
PDS BIOTECHNOLOGY CORPPDSB$26.4K30,0000.02%flat9qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 59.5%Energy 10.1%Semiconductors & Electronics 4.6%Healthcare Services 4.4%Autos & Aerospace 3.0%Telecom & Media 2.5%Mining & Metals 2.2%Software & IT Services 2.2%Retail & Consumer 2.0%Other sectors 1.6%Not classified 7.9%
 
SectorValueShare
Biotech & Pharma$91.0M59.5%
Energy$15.4M10.1%
Semiconductors & Electronics$7.1M4.6%
Healthcare Services$6.8M4.4%
Autos & Aerospace$4.5M3.0%
Telecom & Media$3.9M2.5%
Mining & Metals$3.4M2.2%
Software & IT Services$3.3M2.2%
Retail & Consumer$3.1M2.0%
Other sectors$2.5M1.6%
Not classified$12.1M7.9%

What the disclosed book did

This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.

QuarterBookMarket DifferencePriced
Q2 2026+15.9%+14.8%+1.1%100%
Q1 2026+5.1%-4.6%+9.7%97%
Q4 2022+1.8%+7.1%-5.2%100%
Q3 2022-0.2%-5.3%+5.2%96%
Q2 2022-24.7%-16.5%-8.2%100%
Q1 2022-24.1%-4.9%-19.2%100%
Q4 2021-24.6%+10.7%-35.3%94%
Q3 2021-1.3%+0.3%-1.6%99%

Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$153.1M622015121466.0%29
Q1 2026$127.2M562012112273.6%38
Q4 2025$123.7M5847566067.2%48
Q3 2022$72.5M71135162068.9%34
Q2 2022$71.5M78115261868.6%43
Q1 2022$94.5M8589241563.3%41
Q4 2021$138.3M921515283160.8%34
Q3 2021$193.0M1082620113560.4%47
Q2 2021$194.6M117000056.8%47

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.